Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study

por van Putten, J W G, Eppinga, P, Erjavec, Z, de Leede, G, Nabers, J, Smeets, J B E, Sleijfer, D Th, Groen, H J M
Publicado 2000

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

por Wachters, F M, van Putten, J W G, Kramer, H, Erjavec, Z, Eppinga, P, Strijbos, J H, de Leede, G P J, Boezen, H M, de Vries, E G E, Groen, H J M
Publicado 2003